BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22480452)

  • 21. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hematologic effects of clozapine: a review of the international experience].
    Lamarque V
    Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P; Barnes P
    Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
    Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
    J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
    Hill GR; Harrison-Woolrych M
    N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
    Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine and agranulocytosis: re-assessing the risks.
    Drew L
    Australas Psychiatry; 2013 Aug; 21(4):335-7. PubMed ID: 23804114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices.
    Peacock L; Gerlach J
    J Clin Psychiatry; 1994 Feb; 55(2):44-9. PubMed ID: 8077154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
    Ip J; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White blood cell monitoring during long-term clozapine treatment.
    Cohen D; Monden M
    Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up].
    Pons A; Undurraga J; Batalla A; Bernardo M
    Rev Psiquiatr Salud Ment; 2012; 5(1):37-42. PubMed ID: 22854502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agranulocytosis: incidence and risk factors.
    Alvir JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 36. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand.
    Tunsirimas N; Pariwatcharakul P; Choovanichvong S; Ratta-Apha W
    Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
    Honigfeld G
    Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic.
    Amsler HA; Teerenhovi L; Barth E; Harjula K; Vuopio P
    Acta Psychiatr Scand; 1977 Oct; 56(4):241-8. PubMed ID: 920225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC; Dettling M; Cascorbi I; Mosyagin I; Salisbury BA; Pierz KA; Zou W; Whalen H; Malhotra AK; Lencz T; Gerson SL; Kane JM; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.